Two days ago, the WSJ’s Fed watchers Jon Hilsenrath and Nick Timiraraos started off their [...]
With the economy – and the future of corporate profits – now one giant question [...]
Hot on the heels of positive-sounding news on Gilead’s anti-viral therapy drug Remdesivir, Salveen Richter, [...]
Submitted by Wolf Richter of Wolf Street Dividend yield can be an irresistible siren song [...]
Authored by Sam Leith via UnHerd.com, “Yikes,” I thought this morning. “My profession is trying to [...]
Authored by Soeren Kern via The Gatestone Institute, The European Union has caved in to [...]
Authored by Susan Crabtree via RealClearPolitics.com, It’s a portrait of contrasts in the age of [...]
Last week President Trump suggested that injecting ultraviolet light into the body could be one [...]
Reading and math scores in the US have suffered ‘historic’ declines since most states implemented [...]
Two weeks ago we reported that in the rush to flood the population with plastic [...]
